The Trump administration is investing over $25 million to fast-track research on the psychedelic drug ibogaine to treat PTSD and other mental illnesses
Lifestyle – 13 outlets
The Independent
Trump team funds controversial psychedelic ibogaine for veteran PTSD study
Trump administration will fund new research on controversial psychedelic drug ibogaine
Boston Herald
Trump administration will fund new research on controversial psychedelic drug ibogaine
Local 10 WPLG
Trump administration will fund new research on controversial psychedelic drug ibogaine
Orlando Sentinel
Trump administration will fund new research on controversial psychedelic drug ibogaine
South Florida Sun Sentinel
Trump administration will fund new research on controversial psychedelic drug ibogaine
The Mercury News
Trump administration will fund new research on controversial psychedelic drug ibogaine
The Philadelphia Inquirer
Trump administration will fund new research on controversial psychedelic drug ibogaine
The San Diego Union-Tribune
Trump administration will fund new research on controversial psychedelic drug ibogaine
Toronto Star
Trump administration will fund new research on controversial psychedelic drug ibogaine seen
Washington Examiner
Winnipeg Free Press
Trump administration will fund new research on controversial psychedelic drug ibogaine
WRAL
Trump administration will fund new research on controversial psychedelic drug ibogaine seen
Times Colonist
Trump administration will fund new research on controversial psychedelic drug ibogaine